Inmolecule Nanotech (XPAR:MLINA) FCF Margin %: 0.00% (As of Dec. 2024)


XPAR:MLINA Inmolecule Nanotech SA XPAR:MLINA
6 GF Score
Price €4.08
! 2 Warning Signs
View Full Analysis

What is Inmolecule Nanotech FCF Margin %?

Inmolecule Nanotech XPAR:MLINA 6 FCF Margin % is 0.00% as of Dec. 2024. GuruFocus rates XPAR:MLINA with a GF Score™ of 6/100. The stock has 2 warning signs investors should review. Among 957 Biotechnology companies, Inmolecule Nanotech ranks worse than 104493.1% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Inmolecule Nanotech's Free Cash Flow for the six months ended in Dec. 2024 was €0.00 Mil. Inmolecule Nanotech's Revenue for the six months ended in Dec. 2024 was €1.98 Mil. Therefore, Inmolecule Nanotech's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, Inmolecule Nanotech's current FCF Yield % is 0.00%.

The historical rank and industry rank for Inmolecule Nanotech's FCF Margin % or its related term are showing as below:


XPAR:MLINA's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.


Inmolecule Nanotech FCF Margin % Related Terms


Inmolecule Nanotech FCF Margin % Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech FCF Margin % Chart

Inmolecule Nanotech Annual Data
Trend Dec23 Dec24
FCF Margin %
0.00 0.00

Inmolecule Nanotech Semi-Annual Data
Dec23 Dec24
FCF Margin % 0.00 0.00

XPAR:MLINA vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Inmolecule Nanotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inmolecule Nanotech FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inmolecule Nanotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Inmolecule Nanotech's FCF Margin % falls into.


XPAR:MLINA
6GF Score
Inmolecule Nanotech SA XPAR:MLINA
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inmolecule Nanotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Inmolecule Nanotech's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=0/1.981
=0.00 %

Inmolecule Nanotech's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=0/1.981
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Inmolecule Nanotech (XPAR:MLINA) has a FCF Margin % of 0.00% as of Dec. 2024. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Inmolecule Nanotech and its competitors. According to the industry distribution chart, Inmolecule Nanotech ranks #999999 out of 957 companies in the Biotechnology industry.
Is Inmolecule Nanotech's FCF Margin % too high?
Inmolecule Nanotech's current FCF Margin % is 0.00%. Based on the distribution chart, Inmolecule Nanotech ranks #999999 out of 957 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Inmolecule Nanotech has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Inmolecule Nanotech ranks #999999 out of 957 companies for FCF Margin %. This places Inmolecule Nanotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Inmolecule Nanotech and its competitors. Inmolecule Nanotech's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (XPAR:MLINA) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Inmolecule Nanotech's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Inmolecule Nanotech (XPAR:MLINA), the current FCF Margin % is 0.00% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inmolecule Nanotech Business Description

Address Paseo de la Castellana 91, 4th Floor, Madrid, ESP, 28046
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
6GF Score

Get the complete analysis for XPAR:MLINA

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.08
Price